Stock data
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC) reported revenue of US$7.42M and net income of -US$2.98M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$7.42M | US$1.09M | -US$2.97M | -US$2.98M | — |
| 2024 | US$9.51M | US$1.29M | -US$1.57M | -US$1.60M | — |
| 2023 | US$9.77M | US$1.33M | -US$2.59M | -US$2.63M | — |
| 2022 | US$10.93M | US$1.26M | -US$0.29M | -US$0.36M | — |
| 2021 | US$13.36M | US$2.27M | US$1.06M | US$0.75M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.08M | -US$0.29M | — |
| 2026-03-31 | US$0.02M | -US$0.54M | — |
| 2025-12-31 | US$0.48M | -US$1.04M | — |
| 2025-09-30 | US$2.54M | -US$0.71M | — |
| 2025-06-30 | US$2.26M | -US$0.62M | — |
| 2025-03-31 | US$2.14M | -US$0.62M | — |
| 2024-12-31 | US$2.52M | -US$0.35M | — |
| 2024-09-30 | US$2.63M | -US$1.35M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.